Mednarodna primerljivost uspešnosti zdravljenja raka v Sloveniji
Abstract
Background: The aim of this overview is to show time trends of 5-year relative survival rates of some malignant diseases in Slovenia, to compare them with other countries of the European Union (EUROCARE 4) and to compare incidence and mortality rates for breast cancer. The 5-year relative survival is improving with timo for most cancers, the difference in survival rates between men and women is diminishing. Survival rate for all cancers in men is between the lowest in Europe, mainly on the account of low survival in prostate cancer, a frequent cancer in men. Cancers that are treated centrally, mainly at the Institute of Oncology Ljubljana have very good survival rates, above European mean, some even among the best in Europe (thyroid, Hodgkin’s disease, soft tissue sarcomas, non-Hodgkin lymphomas) while worse survival of cancers treated all over Slovenia is reported.
Downloads
References
Pompe-Kirn V, Zakotnik B, Volk N, Benulič T, Škrk J. Preživetje bolnikov z rakom v Sloveniji: 1963–1990. Ljubljana: Onkološki inštitut, 1995: 121–6.
Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolnikov z rakom v Sloveniji: 1983–1997. Ljubljana: Onkološki inštitut, 2003: 16–24.
Primic-Žakelj M, Bračko M, Hočevar M, Pompe-Kirn V, Strojan P, Zadnik V, et al. Incidenca raka v Sloveniji 2004. Poročilo št. 46. Ljubljana: Onkološki inštitut, 2005: 84.
Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncology 2007; 8: 773–83.
Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangoni L, Kunkler I. Recent cancer survival in Europe: a period analysis 2000–02 of the EUROCARE-4 data. Lancet Oncology 2007; 8: 786–96.
Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004–30.
Jonsson B, Wilking N. The burden and cost of cancer. Ann Oncol 2007; 18: Suppl. 3: 2–67.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
